[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.28262220 [View]
File: 950 KB, 1197x624, buy PRPO anon!.png [View same] [iqdb] [saucenao] [google]
28262220

PRPO (mkt cap: 53.23M): Recently launched COVID POC tests (point of care tests, basically at home COVID antibody tests). COVID testing market was about $84.4 billion (source: grandviewresearch) last year and without a doubt it will continue to grow fast with the vaccine roll-out (kit to test yourself to see if you already have antibodies and/or monitor after taking shots all AT HOME) as well as testing before travel as, which will be increasingly required around the world. The company just inked major deals with two largest cancer centers for it's best-in-class cancer screening and there will be more to join.
"Growth potential" is an understatement - this company IS growing fast. Pay attention to the trend: (revenue) 2017: $1.7M, 2018: $2.9M, 2019: 3.1M, TTM: $4.8M. With cancer screening and COVID testing, the revenue will be surging and management makes confident and bullish projections for good reason. This is one of the best growth micro cap stocks out there and I don't believe this ridiculously cheap valuation will stay for long.

>> No.27967608 [View]
File: 950 KB, 1197x624, buy PRPO anon!.png [View same] [iqdb] [saucenao] [google]
27967608

ATTENTION /smg/, I PRESENT THE NEW MICROCAP HIGHLY SHORTED SHITSTOCK TO SHILL TO THE BOT SCRAPERS AND REDDIT:

PRPO (mkt cap: 53.23M): Recently launched COVID POC tests (point of care tests, basically at home COVID antibody tests). COVID testing market was about $84.4 billion (source: grandviewresearch) last year and without a doubt it will continue to grow fast with the vaccine roll-out (kit to test yourself to see if you already have antibodies and/or monitor after taking shots all AT HOME) as well as testing before travel as, which will be increasingly required around the world. The company just inked major deals with two largest cancer centers for it's best-in-class cancer screening and there will be more to join.
"Growth potential" is an understatement - this company IS growing fast. Pay attention to the trend: (revenue) 2017: $1.7M, 2018: $2.9M, 2019: 3.1M, TTM: $4.8M. With cancer screening and COVID testing, the revenue will be surging and management makes confident and bullish projections for good reason. This is one of the best growth micro cap stocks out there and I don't believe this ridiculously cheap valuation will stay for long.

>> No.27894771 [View]
File: 950 KB, 1197x624, buy PRPO anon!.png [View same] [iqdb] [saucenao] [google]
27894771

>>27894178
>>27894382
here you go weeb

Navigation
View posts[+24][+48][+96]